Remove tag digital-engagement
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

But there are concerns to developing DCTs including lack of standardization and validation, regulatory and ethical uncertainties, engagement vs. coercion, data security and privacy issues, technological literacy and access, resistance to change and adoption, and lack of “safe” sharing. from 2021 to 2026.

article thumbnail

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

For the theme of building partnerships, community engagement was identified as particularly effective for recruitment of racial and ethnic minority groups. In terms of untapped potential, the engagement with the community, taking the time to identify who folks are and speak face to face. Ask and engage community partners.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. The key is adapting existing legacy and traditional printed material for the digital environment.”.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Analysing the world of digitally-native brands highlights three standout ways in which parts of their approach could be brought to the pharmaceutical world.

Branding 130
article thumbnail

How pharma marketing can stay ahead of the evolving customer journey

pharmaphorum

Focus New developments in data and digital are changing traditional customer journeys and forcing pharmaceutical companies to evolve in order to keep up. But, as they push the envelope, what are the implications for pharma’s work in customer engagement?

article thumbnail

Patient adherence – the key to restoring trust in pharma

pharmaphorum

Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. Patient engagement solutions can also help reduce the discrepancy between the efficacy of medications in clinical trials and their effectiveness in real-world use.

article thumbnail

Leading innovators in peptide nano-particle conjugates for the pharmaceutical industry

Pharmaceutical Technology

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Antibody 130